Search result for NTRK
Sources suggest a surge in Cancer drugs’ share by FDA approvals
Report developed by Tufts Center for the Study of Drug Development has made a comparison of FDA approved cancer drugs which have raised from 4% in the 1980s to 27% since 2010. Experts speculate this to the oncology success rate, in addition to pharmaceutical companies’ new approach to drug develo...